Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
9.97
-0.10 (-0.99%)
Jul 29, 2026, 4:00 PM EDT - Market closed
[Name] Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, [Name] stock has a consensus rating of "Buy" and an average price target of $21.83. The average 1-year stock price forecast is 118.96% higher than the current stock price, while the lowest is $16 (+60.48%) and the highest is $30 (+200.90%).
Price Target: $21.83 (+118.96%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jun 3, 2026.
Analyst Ratings
The average analyst rating for [Name] stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 9 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Reiterates $20 | Hold | Reiterates | $20 | +100.60% | Jun 3, 2026 |
| Wedbush | Wedbush | Hold Maintains $16 | Hold | Maintains | $16 | +60.48% | May 19, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 15, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $20 | Buy | Maintains | $20 | +100.60% | May 15, 2026 |
Financial Forecast
Revenue This Year
4.25M
from 244.06M
Decreased by -98.26%
Revenue Next Year
18.91M
from 4.25M
Increased by 344.71%
EPS This Year
-5.19
from 2.30
EPS Next Year
-5.59
from -5.19
EPS and Forward PE are based on non-GAAP adjusted numbers.